CG
NUVL

Cutler Group’s Nuvalent NUVL Stock Holding History

Cutler Group’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,400
Closed -$103K – 3180
2023
Q4 		$103K Buy
+1,400
New +$86.6K 0.01% 1044

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Cutler Group's NUVL Position: Q1 2024 in Review

Cutler Group sold out of Nuvalent (NUVL) in Q1 2024, closing a stake of 1,400 shares — an estimated $103K sold.

Cutler Group first reported a position in NUVL in Q4 2023 and held it in 1 quarter. The position peaked at $103K in Q4 2023. 180 funds tracked by Wall St. Rank hold NUVL as of Q1 2024.

  • Cutler Group reported no remaining Nuvalent position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 1,400 Nuvalent shares in Q1 2024, an estimated $103K.
  • Cutler Group first reported a position in Nuvalent in Q4 2023 and held it in 1 quarter.
  • Cutler Group's Nuvalent position peaked at $103K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Nuvalent as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.